Professional Documents
Culture Documents
PERTEMUAN KE 2
Pasien S, laki-laki, 49 th
Masuk RS via IGD pada Tgl.15-04-2012 jam 17:01:59
IGD
Keadaan Umum: buruk
Keluhan utama: lemas ± 2 hari, mual (+), sulit diajak komunikasi, BAK sedikit, mata: anemis (+).
GDS: 197 mg/dL.
Diagnosa utama: CRF
Diagnosa banding: ARF
Diagnosa Komorbid: susp.Leptospirosis
Suhu: 36°C, Tekanan darah: 160/80 mmHg, Pernapasan: 20 x/menit.
RAWAT INAP
Anamnesa:
± 2 hari lemas, mual (+), sulit diajak komunikasi.
Pemeriksaan:
Tanda vital: suhu: 36°C, TD: 160/80 mmHg, RR: 20x/menit.
Pemeriksaan fisik: KU lemah apatis
Mata: anemis (+)
THT: napas cuping (-)
Thorax: C bising (-), P: sp ves
Abdomen: supel, bising usus (+) N
Ekstrimitas: akral dingin
Diagnosa Kerja: Observasi CRF
Diagnosa Banding: ARF, Leptospirosis
Hasil Pemeriksaan EKG: sinus bradikardia
Laju Filtrasi Glomerulus (LFG) = 8,91
DATA LABORATORIUM
DATA KLINIS
Suhu °C 36 - 36 37,8
Tekanan Darah mmHg 110/80 - 160/80 160/90
Pernapasan kali/menit 20 – 24 - 20 -
Pertanyaan :
1. Sebutkan tanda-tanda yang menunjukkan terjadi penyakit GGA pada kasus diatas!
2. Kasus diatas termasuk GGA jenis apa?
3. Bagaimana tatalaksana terapi yang tepat untuk kasus diatas?
4. Bagaimana monitoringnya?
O2 nasal 4 l/menit
D5 iv 12tts/mnt
Aminoleban iv 1 kolf/hri
Aminepron po 3x2
Starquin
iv 200 mg 2x200 mg
(Ciprofloksasin)
1-0-0
Adalatoros
po 30 mg
(Nifedipin) 2-0-0
ISDN po 10 mg 3x1
Valsartan po 80 mg 2-0-0
Concor
po 2,5 mg 2-0-0
(Bisoprololfumarat)
Codein po 10 mg prn
PRC 1 kolf
Tekanandarah 190/ 160/ 180/ 160/ 140/ 160/ 170/ 190 190/ 200 180 160/
(120/80 120 90 120 110 90 100 120 / 120 /12 /12 120
mmHg) 120 0 0
Nadi 84 84 84 80 84 80 96 86 84 88 88 84
(80-100x/mnt)
RR 20 20 20 20 20 20 20 20 20 20 20 20
(20-24x/mnt)
Suhu 37 36 36 36 36 36 36 36 36 38 37 36
(36,5-37,5o C)
Sesak + + +
Batuk + + + +
Lemah + + + + + + + + + + + +
Parameter Kadar 3/5 4/5 4/5 5/5 7/5 7/ 11/5 11/5 11/5 12/5
normal (post 5 pre post
op)
GDP 60-110 71
mg/dl
GD2PP <125 82
mg/dL
Cl 97-103 93 95
mmol/L
pO2 80 – 100 60 74
mmHg
3. R.T. is a 60-year-old HD patient who has had ESRD for 10 years. His HD access is a left rteriovenous
fistula. He has a history of hypertension, CAD, mild CHF, type 2 diabetes mellitus, and a seizure disorder.
Medications: Epoetin 14,000 units 3 times/week at dialysis; multivitamin (Nephrocaps) once daily;
atorvastatin 20 mg/day; insulin; calcium acetate 2 tablets 3 times/day with meals; phenytoin 300 mg/day;
and intravenous iron 100 mg/month. Laboratory values: Hemoglobin 10.2 g/dL; immunoassay for PTH
(iPTH) 800 pcg/mL; Na 140 mEq/L; K 4.9 mEq/L; Cr 7.0 mg/dL; calcium 9 mg/dL; albumin 2.5 g/dL; and
phosphorus 7.8 mg/dL. Serum ferritin is 200 ng/mL, and transferrin saturation is 32%. The RBC indices are
normal. His WBC is normal. He is afebrile. What a most likely contributing to relative epoetin resistance in
this patient? In addition to diet modification and emphasizing adherence, what the best approach to
managing this patient’s hyperparathyroidism and renal osteodystrophy?
4. A.M. is a 75-year-old man who presents to your institution with abdominal pain and dizziness. He has a brief
history of gastroenteritis and has had nothing to eat or drink for 24 hours. His blood pressure (BP) reading
while sitting is 120/80 mm Hg, which drops to 90/60 mm Hg when standing. His heart rate is 90
beats/minute. His basic metabolic panel shows sodium (Na) 135 mEq/L; chloride (Cl) 108 mEq/L;
potassium (K) 4.7 mEq/L; CO 2 26 mEq/L; blood urea nitrogen (BUN) 40 mg/dL; serum creatinine (SCr) 1.5
mg/dL; and glucose 188 mg/dL. He has no known drug allergies. His weight is 92.5 kg, and his height is
6′1′′. What the best approach to treat this patient?
5. M.M.R., a 59-year-old patient who has had endstage renal disease (ESRD) for 10 years, is maintained on
chronic hemodialysis (HD). He has a history of hypertension, coronary artery disease (CAD), mild
congestive heart failure (CHF), and type 2 diabetes mellitus. Medications are as follows: epoetin 10,000
units intravenously 3 times/ week at dialysis; Nephrocaps once daily; atorvastatin 20 mg/day; insulin; and
calcium acetate 2 tablets 3 times/day with meals. Laboratory values are as follows: hemoglobin 9.2 g/dL,
parathyroid hormone (PTH) 300 pg/mL, Na 140 mEq/L, K 4.9 mEq/L, Cr 7.0 mg/dL, calcium 9 mg/dL,
albumin 3.5 g/L, and phosphorus 4.8 mg/dL. He has a serum ferritin concentration of 80 ng/mL and a
transferrin saturation of 14%. The red blood cell count (RBC) indices (mean corpuscular volume, mean
corpuscular hemoglobin count) are normal. His white blood cell count (WBC) is normal. He is afebrile.
What the best approach to managing anemia in this patient?